A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.

HomeClinical Trial SupplyBiosimilar Services

Clinical Trial Supply

Biosimilar Services.

Established global network.

Sourcing Innovator products for use in Biosimilar development can be extremely challenging. There are many factors that need to be considered, including manufacturer restrictions, regulatory barriers and complex supply chains. The Bionical Emas Biosimilar Services team provide supply strategies to help navigate these complexities.

Whether you require multiple lots and expiries for early-stage analytical development, or you are running a global Phase III study, we ensure you have access to the innovator products you need to conduct your research. Our established global network of direct manufacturer relationships and audited suppliers ensures we can access the most challenging and restricted products.

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.